- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
A leavepiece and journal ad for Bonviva used the headline claim “Building bones”. PMCPA ruled it implied a direct bone-forming (anabolic) effect,…
GSK challenged an AstraZeneca Symbicort SMART leavepiece for an unqualified ‘Rx… plus as needed’ dosing line. The Panel found it reflected the…
Allergan challenged Pfizer Inc’s support for two AAO 2006 meetings linked to a wax museum and a nightclub. Panel found Pfizer UK…
AstraZeneca-funded statins insert in The Pharmaceutical Journal was ruled promotional for Crestor, misleading on targets/licence/safety and missing prescribing info. Multiple Code breaches…
A GP alleged a Spiriva journal ad implied COPD cure. Panel found the audience would understand COPD is incurable and the wording…
A GP mailing for Aprovel/CoAprovel implied cardiovascular risk reduction from treating BP to target. PMCPA ruled the claims misleading and unsubstantiated, breaching…
A public complaint challenged a Rectogesic press release implying it aided fissure healing. PMCPA ruled the statement inaccurate (Clauses 9.1, 20.2) but…
Shire alerted the PMCPA that a Calcichew-D3 Forte ad (linked to a prior breach campaign) ran in MIMS despite instructions to destroy…
PMCPA case AUTH/3003/12/17 (Director v Clinuvel UK) concerning clinical trial disclosure for Scenesse. Outcome: no breach; matter was outwith the scope of…
A consultant complained to the PMCPA about Takeda’s promotion of vedolizumab. The case was concluded with no breach because the matter was…
PMCPA complaint about clinical trial disclosure for Xiapex. The matter was ruled outwith the scope of the ABPI Code; no breach found…
PMCPA case AUTH/2613/6/13 about a Cerazette discount scheme. The matter was found to be outwith the scope of the ABPI Code (2012)…
MSD’s nurse audit programme was found to be linked to Cozaar promotion via branded training slides and targeting criteria. Breaches of Clauses…
Anonymous consultant alleged pre-licence promotion of Epidiolex at a hospital MDT meeting. Panel had concerns about documentation but found, on balance, it…
A PCT medicines management team member alleged MSD’s Januvia budget impact model was misleading on heart failure and competitor costs. Panel found…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.